论文部分内容阅读
目的:探讨了阿奇霉素联合红霉素治疗小儿支原体肺炎的疗效观察。方法:回顾性分析我院2011年2月~2013年4月收治小儿支原体肺炎患儿90例的临床资料,随机将全部患者分为观察组和对照组,对照组给予阿奇霉素治疗,观察组采取阿奇霉素联合红霉素治疗,比较两组的退热、止咳时间和住院时间、临床疗效及其不良反应。结果:观察组退热时间、止咳时间和住院时间分别与对照组比较,差异有统计学意义(P<0.05)。观察组总有效率与对照组比较,差异有统计意义(P<0.05)。观察组有8例出现不良反应。对照组有6例出现不良反应。结论:阿奇霉素联合红霉素治疗小儿支原体肺炎临床效果显著,在较短时间内能够改善患儿临床症状和体征,值得借鉴。
Objective: To investigate the efficacy of azithromycin combined with erythromycin in the treatment of children with mycoplasma pneumonia. Methods: The clinical data of 90 children with mycoplasma pneumonia admitted in our hospital from February 2011 to April 2013 were retrospectively analyzed. All the patients were randomly divided into observation group and control group. The control group was treated with azithromycin. The observation group was treated with azithromycin Combined with erythromycin treatment, the two groups were compared fever, cough and hospital stay, clinical efficacy and adverse reactions. Results: The observation group, fever, cough and hospital stay were compared with the control group, the difference was statistically significant (P <0.05). The total effective rate of observation group compared with the control group, the difference was statistically significant (P <0.05). In the observation group, 8 patients showed adverse reactions. There were 6 adverse reactions in the control group. Conclusion: Azithromycin combined with erythromycin in children with mycoplasma pneumonia clinical effect is significant, in a relatively short period of time can improve clinical symptoms and signs in children, it is worth learning from.